Skip to content

A Cohort of Patients With Chronic Pulmonary Disease

A Long-term, Prospective, Observational Cohort of Patients With Chronic Pulmonary Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04050943
Enrollment
100
Registered
2019-08-09
Start date
2019-08-22
Completion date
2021-09-01
Last updated
2019-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Pulmonary Disease

Brief summary

This is a longitudinal study of following chronic pulmonary disease patients to observe and predict the clinical outcomes of these patients.

Detailed description

In patients with chronic pulmonary disease, impaired pulmonary function and limited exercise capacity, is a complex clinical syndrome with a wide range of underlying causes, which may result in worse quality of life and high economic burden. This is a longitudinal study of following chronic pulmonary disease patients, recording the clinical, pathophysiology, and psychological parameters, to observe and predict the clinical outcomes of these patients.

Interventions

Recording the clinical, pathophysiology, and psychological parameters, to observe and predict the clinical outcomes of these patients.

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-80, males and females 2. Patients are diagnosed as the obstructive pulmonary disease according to the clinical practice. 3. Willing to participate in the study. 4. Being able to provide informed consent.

Exclusion criteria

1. Subjects with severe heart failure, severe arrhythmias, unstable angina, and malignant comorbidities. 2. Subjects with significantly impaired cognitive function and are unable to fulfill the study requirement (unable to provide informed consent) 3. Subjects who participated in another trial within 30 days prior to the planned start of the study 4. Subjects with cancer or have had cancer in the 5 years prior to study entry.

Design outcomes

Primary

MeasureTime frameDescription
Rate of acute exacerbations1 yearThe rate of exacerbations within 1 year of these patients will be tracked.

Secondary

MeasureTime frameDescription
Survival1 yearThe rate of survival within 1 year of these patients will be tracked.
Forced expiratory volume in 1 second1 yearForced expiratory volume in 1 second is a marker used to measure lung function and can help you monitor your lung diseases over time.
Health related quality of life: questionnaires1 yearUsing questionnaires to reflect the patients' health related quality of life. The questionnaires include: 1. SF-36 (scores range between 0 and 100 and higher scores are attributed to better quality of life.) 2. St. George's Respiratory Questionnaire (scores range between 0 and 100 and higher scores are attributed to worse quality of life.) 3. Severe Respiratory Insufficiency Questionnaire (scores range between 0 and 100 and higher scores are attributed to better quality of life.)
6-minute walk test1 yearThe 6-minute walk test plays a key role in evaluating functional exercise capacity, assessing prognosis and evaluating response to treatment across a wide range of respiratory diseases.

Countries

China

Contacts

Primary ContactLili Guan, PhD
dr_nickguan@163.com+8613422288665

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026